1 Min Read
June 6 (Reuters) - Critical Outcome Technologies Inc :
* Critical Outcome Activates Second Clinical Trial Site for Its COTI-2 Gynecological Cancer Study Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.